These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 6366089
1. Implications of subcellular steroid binding sites in endometrial cancer, determined by an immunofluorescent steroid-antibody technique and biochemical assay. Tamaya T, Kimura J, Tsurusaki T, Kato Y, Fujimoto J, Okada H. Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):113-8. PubMed ID: 6366089 [Abstract] [Full Text] [Related]
2. [Cellular heterogeneity of steroid reactivity in human endometrial carcinoma: an approach by an immunofluorescent steroid-antibody technique (author's transl)]. Kato Y, Kimura J, Harada K, Hirose T, Nawa M, Okada H. Acta Obstet Gynaecol Jpn; 1980 Dec; 32(12):2007-16. PubMed ID: 7010880 [Abstract] [Full Text] [Related]
3. [Immunofluorescent analysis of intracellular localization of estrogen and progesterone in normal human endometrial cells (author's transl)]. Kato Y, Kimura J, Harada K, Hirose T, Nawa M, Okada H. Acta Obstet Gynaecol Jpn; 1980 Dec; 32(12):1999-2006. PubMed ID: 7010879 [Abstract] [Full Text] [Related]
4. Correlation between estradiol-17 beta and progesterone cytosol receptor concentration, histologic differentiation and 3H-thymidine incorporation in endometrial carcinoma. Lindahl B, Alm P, Borg A, Fernö M, Grundsell H, Johnsson JE, Norgren A, Tropé C. Anticancer Res; 1982 Dec; 2(4):203-7. PubMed ID: 7149649 [Abstract] [Full Text] [Related]
5. Is immunohistochemical analysis of oestrogen and progesterone receptors in endometrial carcinoma superior to the radioligand binding assay? Snijders MP, De Goeij AF, Koudstaal J, Rousch MJ, Scheres HM, Stoot JE, Bosman FT. J Pathol; 1990 Jun; 161(2):129-35. PubMed ID: 2199640 [Abstract] [Full Text] [Related]
6. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer. Kauppila AJ, Isotalo HE, Kivinen ST, Vihko RK. Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579 [Abstract] [Full Text] [Related]
9. Histochemical determination of estrogen and progesterone binding in fine needle aspirates of breast cancer. Correlation with conventional biochemical assays. Curtin CT, Pertschuk LP, Mitchell V. Acta Cytol; 1982 Oct; 26(6):841-6. PubMed ID: 6961721 [Abstract] [Full Text] [Related]
10. Nuclear translocation of progesterone receptor--progestogen complex in vitro. Tamaya T, Tsurusaki T, Ide N, Yamada T, Murakami T, Wada K, Fujimoto Z, Okada H. Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jan; 35(1):77-82. PubMed ID: 6827166 [Abstract] [Full Text] [Related]
18. Sex steroid receptors in endometrial cancer. Chambers JT. Yale J Biol Med; 1988 Feb 26; 61(4):339-50. PubMed ID: 3055700 [Abstract] [Full Text] [Related]
19. [Cell culture--its application in the study of hormone and endometrial carcinoma and feed-back to clinical medicine]. Kuramoto H. Nihon Sanka Fujinka Gakkai Zasshi; 1988 Aug 26; 40(8):1050-5. PubMed ID: 3150847 [Abstract] [Full Text] [Related]